These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34418452)

  • 61. Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release.
    Ago Y; Tanaka T; Kita Y; Tokumoto H; Takuma K; Matsuda T
    Neuropharmacology; 2012 Mar; 62(4):1634-9. PubMed ID: 22001792
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.
    Yorgason JT; Hedges DM; Obray JD; Jang EY; Bills KB; Woodbury M; Williams B; Parsons MJ; Andres MA; Steffensen SC
    Psychopharmacology (Berl); 2020 May; 237(5):1317-1330. PubMed ID: 31965252
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice.
    Miyamoto Y; Ishikawa Y; Iegaki N; Sumi K; Fu K; Sato K; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Uno K; Nitta A
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1283-94. PubMed ID: 24559655
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine.
    Chen H; Wu J; Zhang J; Fujita Y; Ishima T; Iyo M; Hashimoto K
    Psychopharmacology (Berl); 2012 Jul; 222(1):37-45. PubMed ID: 22200890
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
    Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
    J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Repeated clorgyline treatment inhibits methamphetamine-induced behavioral sensitization in mice.
    Kitanaka N; Kitanaka J; Takemura M
    Neurochem Res; 2005 Apr; 30(4):445-51. PubMed ID: 16076014
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area.
    Kuo CC; Shen H; Harvey BK; Yu SJ; Kopajtic T; Hinkle JJ; Kyrkanides S; Katz JL; Wang Y
    Psychopharmacology (Berl); 2016 Feb; 233(4):661-72. PubMed ID: 26554386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A single administration of methamphetamine to mice early in the light period decreases running wheel activity observed during the dark period.
    Kitanaka N; Kitanaka J; Hall FS; Uhl GR; Watabe K; Kubo H; Takahashi H; Tatsuta T; Morita Y; Takemura M
    Brain Res; 2012 Jan; 1429():155-63. PubMed ID: 22079320
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine.
    Ren Q; Zhang JC; Ma M; Fujita Y; Wu J; Hashimoto K
    Psychopharmacology (Berl); 2014 Jan; 231(1):159-66. PubMed ID: 23934209
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in histamine metabolism in the mouse hypothalamus induced by acute administration of ethanol.
    Itoh Y; Nishibori M; Oishi R; Saeki K
    J Neurochem; 1985 Dec; 45(6):1880-5. PubMed ID: 4056796
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Are Histamine H
    Kitanaka N; Hall FS; Tanaka KI; Tomita K; Igarashi K; Nishiyama N; Sato T; Uhl GR; Kitanaka J
    Curr Drug Res Rev; 2022; 14(3):162-170. PubMed ID: 35431009
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dose-dependent changes in the locomotor responses to methamphetamine in BALB/c mice: low doses induce hypolocomotion.
    Singh RA; Kosten TA; Kinsey BM; Shen X; Lopez AY; Kosten TR; Orson FM
    Pharmacol Biochem Behav; 2012 Dec; 103(2):230-6. PubMed ID: 23010423
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
    Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S
    Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
    Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
    J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
    [TBL] [Abstract][Full Text] [Related]  

  • 75. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
    Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
    J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
    Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
    J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
    Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
    Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase.
    Itzhak Y
    J Pharmacol Exp Ther; 1997 Aug; 282(2):521-7. PubMed ID: 9262311
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acupuncture inhibition of methamphetamine-induced behaviors, dopamine release and hyperthermia in the nucleus accumbens: mediation of group II mGluR.
    Kim NJ; Ryu Y; Lee BH; Chang S; Fan Y; Gwak YS; Yang CH; Bills KB; Steffensen SC; Koo JS; Jang EY; Kim HY
    Addict Biol; 2019 Mar; 24(2):206-217. PubMed ID: 29363229
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity.
    Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
    Synapse; 2009 Jan; 63(1):7-14. PubMed ID: 18925659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.